1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GW Pharmaceuticals plc
  6. News
  7. Press Releases
       GB0030544687

GW PHARMACEUTICALS PLC

End-of-day quote London Stock Exchange  -  05/19 06:57:14 pm EDT
0.000000 GBX    0.00%
03/28Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
AQ
03/02Jazz pharmaceuticals announces full year and fourth quarter 2021 financial results
AQ
2021JAZZ PHARMACEUTICALS : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
RE
SummaryNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société GW PHARMACEUTICALS PLC
03/28Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
AQ
03/02Jazz pharmaceuticals announces full year and fourth quarter 2021 financial results
AQ
2021PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in..
AQ
2021PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Yea..
AQ
2021GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Del..
AQ
2021GW PHARMACEUTICALS : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
PR
2021GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2021GW PHARMACEUTICALS : recognised for leadership in prescription cannabis-based medicines wi..
AQ
2021GW PHARMACEUTICALS : Highest British business award goes to cannabis drug developer, GW Ph..
AQ
2021GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines w..
GL
2021JAZZ PHARMACEUTICALS : GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmac..
AQ
2021GW PHARMACEUTICALS PLC : Submission of Matters to a Vote of Security Holders, Other Events..
AQ
2021GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
GL
2021PAO Group, Inc. Stock Rockets 28% After Updates Point Toward Near-Term CBD-Based Nutrac..
AQ
2021JAZZ PHARMACEUTICALS : Announces Proposed Private Offering of Senior Secured Notes
AQ
2021GW PHARMACEUTICALS : receives European Commission approval for EPIDYOLEX (cannabidiol) for..
AQ
2021GW PHARMACEUTICALS PLC : Other Events (form 8-K)
AQ
2021GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) f..
GL
2021These Emerging Companies Have Near Term Catalysts That Could Send Share Prices Soaring
AQ
2021GW PHARMACEUTICALS PLC : Other Events (form 8-K)
AQ
2021PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullis..
AQ
2021GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 202..
GL
2021PAO Group, Inc. Has Two CBD-Based Therapeutics In Play; Planned Launch For One In Septe..
AQ
2021Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates Resp..
AQ
2021GW PHARMACEUTICALS PLC : Other Events (form 8-K)
AQ
2021Here's Why PAO Group Inc. Stock Looks Tremendously Undervalued; Dividend And CBD-Based ..
AQ
2021PAO Group Inc.'s CBD-Based Nutraceutical Shows Promise In Treating COPD... And Could Cr..
AQ
2021GW PHARMACEUTICALS : receives positive CHMP opinion for EPIDYOLEX for use as treatment of ..
AQ
2021GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2021GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use ..
GL
2021GW PHARMACEUTICALS : Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2020 Fina..
AQ
2021PAO Group, Inc. Positions To Accelerate Growth; Investor Interest Pushes Shares 328% Hi..
AQ
2021GW PHARMACEUTICALS : Reports Fourth Quarter and Year-End 2020 Financial Results and Operat..
AQ
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of GW Pharmaceut..
PR
2021GW PHARMACEUTICALS : Jazz to acquire GW Pharmaceuticals for $7.2 billion
AQ
2021GW PHARMACEUTICALS INVESTOR ALERT BY : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
2021GW PHARMACEUTICALS : Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an I..
AQ
2021GW PHARMACEUTICALS PLC : Entry into a Material Definitive Agreement, Regulation FD Disclos..
AQ
2021GWPH MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the Sale..
BU
2021GW PHARMACEUTICALS PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021CANNABIS PATENT LITIGATION UPDATE : Canopy Growth Sues GW Pharma
AQ
2021GW PHARMACEUTICALS : Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sa..
AQ
2021CORRECTING and REPLACING - GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan..
GL
2021GW PHARMACEUTICALS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
AQ
2020GW PHARMACEUTICALS : JAMA Neurology Publishes Phase 3 Study of EPIDIOLEX Oral Solution in ..
AQ
2020JAMA Neurology Publishes Phase 3 Study of EPIDIOLEX® (cannabidiol) Oral Solution in Pat..
GL
2020GW PHARMACEUTICALS : to Present at the 2020 Needham Virtual Epilepsy & Pain – Specia..
AQ
2020GW PHARMACEUTICALS : Greenwich Biosciences to Present Data on EPIDIOLEX Oral Solution at t..
AQ
2020GW PHARMACEUTICALS : Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Ora..
AQ
2020GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference
GL
2020GW PHARMACEUTICALS : Greenwich Biosciences to Present Analysis of Three Clinical Studies o..
AQ
2020GW PHARMACEUTICALS : Greenwich Biosciences to Present Analysis of Three Clinical Studies o..
AQ
2020Greenwich Biosciences to Present Analysis of Three Clinical Studies of Nabiximols for P..
GL
2020GW PHARMACEUTICALS : to Present at the Stifel 2020 Virtual Healthcare Conference
AQ
2020GW PHARMACEUTICALS : to Present at the Stifel 2020 Virtual Healthcare Conference
AQ
2020GW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference
GL
2020GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020GW PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results and Operational Progress
AQ
2020GW PHARMACEUTICALS : Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-..
AQ
2020GW PHARMACEUTICALS PLC : Results of Operations and Financial Condition, Regulation FD Disc..
AQ
2020GW PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results and Operational Progress
AQ
2020GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Pr..
GL
2020GW PHARMACEUTICALS : Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-..
AQ
2020GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis..
GL
2020GW PHARMACEUTICALS : to Report Financial Results and Operational Progress for the Third Qu..
AQ
2020GW PHARMACEUTICALS : to Report Financial Results and Operational Progress for the Third Qu..
AQ
2020GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Thi..
GL
2020GW PHARMACEUTICALS : Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, ..
AQ
2020GW PHARMACEUTICALS : Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, ..
AQ
2020Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken ..
GL
2020GW PHARMACEUTICALS : receives Australian Therapeutic Goods Administration approval for EPI..
AQ
2020GW PHARMACEUTICALS : receives Australian Therapeutic Goods Administration (TGA) approval f..
AQ
2020GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval ..
GL
2020GW PHARMACEUTICALS PLC : Change in Directors or Principal Officers, Financial Statements a..
AQ
2020GW PHARMACEUTICALS : Greenwich Biosciences to Present Data on Safety and Efficacy of Nabix..
AQ
1  2  3  4  5  6  7Next